Single-cell RNAseq Breast Cancer
NCT05807516 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-04-25
Summary
Molecular characterization of persistent tumor cells remaining after NAC and infiltrating immune cells, for example, M2 macrophages, could strongly contribute to identifying targeted therapeutic approaches for this disease.
Conditions
- Breast Neoplasms
Interventions
- OTHER
-
Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
Combined both retrospective and prospective observational design
Sponsors & Collaborators
-
Regina Elena Cancer Institute
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-14
- Primary Completion
- 2022-12-12
- Completion
- 2024-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma
NCT05888636 ·Status: RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries
NCT05769517 ·Status: RECRUITING
-
Implementation of the Methylome in the Characterization of Solid Tumors
NCT07268066 ·Status: RECRUITING
-
Clinical Evaluation of the Scopio Cell Morphology Technology
NCT06574308 ·Status: NOT_YET_RECRUITING
-
Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)
NCT04464122 ·Status: RECRUITING
-
Biomolecular Analysis for Predicting Response to Regorafenib
NCT05759195 ·Status: COMPLETED ·Phase: NA
-
Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression
NCT04137523 ·Status: COMPLETED
-
Identification and Characterization of Predictive Factors of Onset of Bone Metastases in Cancer Patients
NCT03895216 ·Status: COMPLETED
-
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT00974610 ·Status: COMPLETED
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
Molecular Screening for Cancer Treatment Optimization
NCT01566019 ·Status: UNKNOWN ·Phase: NA
-
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
NCT06939049 ·Status: COMPLETED
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Integrated Molecular Profiling in Advanced Cancers Trial
NCT01505400 ·Status: ACTIVE_NOT_RECRUITING
-
CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.
NCT02789384 ·Status: RECRUITING ·Phase: NA
-
Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
NCT00588510 ·Status: COMPLETED
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Evaluation of MCM5 in Postmenopausal Bleeding Patients
NCT05287048 ·Status: UNKNOWN
-
Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
NCT06250010 ·Status: RECRUITING
-
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi
NCT03160183 ·Status: COMPLETED
-
One-step Nucleic Acid Amplification for Detecting Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma
NCT02852343 ·Status: COMPLETED